J Am Pharm Assoc (2003). 2021 Sep-Oct;61(5):e71-e77. doi: 10.1016/j.japh.2021.04.009. Epub 2021 Apr 20.
Coronavirus disease 2019 (COVID-19) has disrupted pharmacy practice. Little research has been done to assess how COVID-19 has affected pharmacists' employment, workload, and feelings of burnout.
The objectives of this study were to characterize the impact of COVID-19 on pharmacists' employment status, workload, and feelings of burnout, as well as to examine emotional health concerns related to COVID-19.
Wisconsin pharmacists were surveyed using an online instrument between August 25, 2020, and September 22, 2020. The data analysis, performed in December 2020, examined employment status, 3 common burnout risk factors (workload, rewards, and social depersonalization), and emotional health concerns related to COVID-19.
Of the 1300 pharmacists, 439 completed the survey (33.8%). The study analysis included pharmacists in community (n = 127) and hospital or health system (n = 107) settings. With regard to employment changes and workload, hospital pharmacists (36%) were more likely to have their hours reduced than community pharmacists (13%) (P < 0.01), and, conversely, community pharmacists (19%) were more likely to have their hours increased than hospital pharmacists (8%) (P = 0.01). For the burnout domain of workload, 45% of the pharmacists reported increased feelings of physical exhaustion at work, and 53% reported increased feelings of emotional exhaustion at work, with no difference between settings. Regarding the burnout domain of rewards, 6% of the hospital pharmacists and 1% of the community pharmacists experienced a reduction in hourly wages or salaries as a result of COVID-19. For the burnout domain of depersonalization, 25% of the pharmacists reported that their ability to connect with colleagues and patients decreased during the COVID-19 pandemic. Additional emotional health concerns reported by the pharmacists included 40% experiencing more anxiety and 25% experiencing more sadness or depression during the COVID-19 pandemic, with no difference between settings.
This study found that the burnout domains related to workload, rewards, and depersonalization were negatively affected by COVID-19. Pharmacy managers need to proactively combat burnout as well as be reactive when employees show signs of burnout to maintain their workforce and meet the COVID-19-associated challenges.
2019 年冠状病毒病（COVID-19）扰乱了药学实践。很少有研究评估 COVID-19 如何影响药剂师的就业、工作量和倦怠感。
本研究的目的是描述 COVID-19 对药剂师就业状况、工作量和倦怠感的影响，并探讨与 COVID-19 相关的情绪健康问题。
2020 年 8 月 25 日至 9 月 22 日期间，威斯康星州药剂师使用在线工具进行了调查。2020 年 12 月进行的数据分析，对就业状况、3 个常见的倦怠风险因素（工作量、奖励和社会去人性化）以及与 COVID-19 相关的情绪健康问题进行了检查。
在 1300 名药剂师中，有 439 名完成了调查（33.8%）。研究分析包括社区（n = 127）和医院或医疗系统（n = 107）环境中的药剂师。就工作时间的变化和工作量而言，医院药剂师（36%）比社区药剂师（13%）更有可能减少工作时间（P < 0.01），而相反，社区药剂师（19%）比医院药剂师（8%）更有可能增加工作时间（P = 0.01）。在工作量的倦怠域中，45%的药剂师报告在工作中感到身体疲惫感增加，53%的药剂师报告在工作中感到情绪疲惫感增加，在设置之间没有差异。关于奖励的倦怠领域，6%的医院药剂师和 1%的社区药剂师因 COVID-19 而导致时薪或工资减少。在去人性化的倦怠领域，25%的药剂师报告说，在 COVID-19 大流行期间，他们与同事和患者联系的能力下降。药剂师报告的其他情绪健康问题包括 40%的人在 COVID-19 大流行期间感到焦虑增加，25%的人感到悲伤或抑郁增加，在设置之间没有差异。
本研究发现，与工作量、奖励和去人性化相关的倦怠领域受到 COVID-19 的负面影响。药房经理需要积极主动地预防倦怠，同时在员工出现倦怠迹象时做出反应，以维持员工队伍并应对与 COVID-19 相关的挑战。
